Abstract of the communication presented at the 3rd International Congress of CiiEM ‘Research and Innovation in Human and Health Sciences. Campus Egas Moniz, Caparica, Portugal, June 20-22, 2018N/

Contente, Bárbara

Fernandes, Ana Isabel

English

Poster presented at the 3rd International Congress of CiiEM - Research and Innovation in Human and Health Sciences. Monte da Caparica, Portugal, 20-22 June 2018N/

Repositório Comum

REFERENCES 1. Luebberding, S., Krueger, N. & Sadick, N. Cellulite: an evidence-based review. Am. J. Clin Dermatol, 2015; 16: 243–56.  2. Turati, F. et al. Efficacy of cosmetic products in cellulite reduction: systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2014; 28(1):1-15. 3. Green, J.B., Cohen, J.L., Kaufman, J., Metelitsa, A.I., Kaminer, M.S. Therapeutic approaches to cellulite. Semin Cutan Med Surg. 2015:34(3):140-3.  ACKNOWLEDGEMENTS Pharmacies (Caldense, Rosa, Santa Catarina, Tornada), where the application of the questionnaire was authorized, and their  collaborators are gratefully acknowledged.    INTRODUCTION Cellulite is characterized by lumpy, dimpled flesh on the thighs, hips, buttocks and abdomen, (Fig.1), sometimes described as orange peel texture (1). Although not a serious medical condition, but rather an aesthetical concern of many adolescent and adult women, it can impact significantly in their self-esteem. Many cellulite treatments are conducted without counseling and supervision of a health professional, disregarding possible interaction with drugs or contraindications due to a pre-existing medical condition. Moreover, remarkable results are advertised and most of these treatments have few scientific support (2,3) and do not live up to their claims.  Anti-cellulite products can be either TOPICAL (COSMETICS) or ORAL (FOOD SUPPLEMENTS), and their consumption pattern and efficacy perception are evaluated in this pilot work. MATERIALS AND METHODS Anonymous questionnaire (n=86), validated and approved by Egas Moniz ethics committee, was applied in pharmacies (May-August 2017), to women ≥15 years old. Sample was characterized regarding socioeconomic status and, those who had already used an anti-cellulite product, were asked about preference (oral/topical), acquisition place, counseling, results obtained upon treatment and efficacy perception. Bárbara Contente & Ana Isabel Fernandes  CiiEM, Instituto Universitário Egas Moniz, 2829-511 Caparica, Portugal   aifernandes@egasmoniz.edu.pt      A SNAPSHOT OF ANTI-CELLULITE PRODUCTS' CONSUMPTION AND PHARMACEUTICAL INTERVENTION     RESULTS The sample was mainly in the age groups of 18-34 (41.86%), 35-55 years (31.40%) and above 56 (20.93%); none of the respondents was bellow 18. Women held a secondary degree (24.42%) or higher (51.18%), lived in the city (69.77%) and considered their economic level as average (74.42%).  Regarding consumption (Fig.2), 41.86% had already used a topical (77.22%), oral (5.56%) or a combination of both (19.44%) products; these were bought mainly in the pharmacy (72.22%), equally used seasonally/randomly (44.44%), mainly under pharmaceutical counseling (50.00%). However, 36.12% reported using the products at their own accord, without intervention of any health professional. Oral products were considered more effective than topical (11.11% vs 5.56%), although 38.89% were deemed to be equally effective and 44.44% did not know. Most women (69.44%) considered to have obtained results from the treatment, though sometimes below the expected (33.33%). DISCUSSION AND CONCLUSIONS  The study has shown that women below 55 years old, with a higher education degree, are the greatest consumers of anti-cellulite products, which are mainly acquired in the pharmacy, though sometimes without pharmaceutical advice.   While considered more efficacious (either alone or in combination with topical), food supplements were less consumed than cosmetics, probably due to the increased risk perception associated with the first. In fact, anti-cellulite products, especially those marketed as food supplements, are not without adverse effects and contraindications.   Pharmaceutical counseling on dispensing anti-cellulite products is thus critical and should be regarded as a differentiating factor of the place of acquisition and an added-value to the product.  Fig. 1. Cellulite affected skin (A) and normal healthy skin (B)  Cellulite bumps Tight elatin fibers Enlarged fat cells and toxic fluids A B Fig. 2. Consumption of anti-cellulite products regarding USE (A), PREFERENCE (B), PERIODICITY OF USE (C), COUNSELLING (D) AND EFFICACY PERCEPTION (E).  Yes; 41,86 No; 55,81 NR; 2,33 A Topical  Oral Both NR/NK B 0 20 40 60 Seasonally No periodicity Continously C Pharmacist Own accord Another health professional Publicity Other D 11,11 5,56 38,89 44,44 0 10 20 30 40 50 E n=86 n=36 Printing was finnanced by FCT – Fundação para a Ciência e a Tecnologia, I.P., project UID/BIM/04585/2016. 

A snapshot of anti-cellulite products’ consumption and pharmaceutical intervention

A snapshot of anti-cellulite products' consumption and pharmaceutical intervention   Bárbara Contente1,2 and Ana I Fernandes1   1.CiiEM − Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, Monte de Caparica, Portugal, 2.Alumni of the Pharmaceutical Sciences Integrated Master.   aifernandes@egasmoniz.edu.pt  Introduction: Cellulite is characterized by lumpy, dimpled flesh on the thighs, hips, buttocks and abdomen, sometimes described as orange peel texture (1). Although not a serious medical condition, but rather an aesthetical concern of many adolescent and adult women, it can impact significantly in their self-esteem. Many cellulite treatments are conducted without counseling and supervision of a health professional, disregarding possible interaction with drugs or contraindications due to a pre-existing medical condition. Moreover, remarkable results are advertised and most of these treatments have few scientific support (2,3) and do not live up to their claims. Anti-cellulite products can be either topical (cosmetics) or oral (food supplements), and their consumption pattern and efficacy perception are evaluated in this pilot work. Materials and Methods: Anonymous questionnaire (n=86), validated and approved by Egas Moniz ethics committee, was applied in pharmacies (May-August 2017), to women ≥15 years old. Sample was characterized regarding socioeconomic status and those who had already used an anti-cellulite product were asked about preference (oral/topical), acquisition place, counseling, results obtained upon treatment and efficacy perception. Results: The sample was mainly in the age groups of 18-34 (41.86%), 35-55 years (31.40%) and above 56 (20.93%); none of the respondents was bellow 18. Women held a secondary degree (24.42%) or higher (51.18%), lived in the city (69.77%) and considered their economic level as average (74.42%). Regarding consumption, 41.86% had already used a topical (77.22%), oral (5.56%) or a combination of both (19.44%) products; these were bought mainly in the pharmacy (72.22%), equally used seasonally/randomly (44.44%), mainly under pharmaceutical counseling (50.00%). However, 36.12% reported using the products at their own accord, without intervention of any health professional. Oral products were considered more effective than topical (11.11% vs 5.56%), although 38.89% were deemed to be equally effective and 44.44% did not know. Most women (69.44%) considered to have obtained results from the treatment, though sometimes below the expected (33.33%). Discussion and Conclusions: The study has shown that women below 55 years old, with a higher education degree, are the greatest consumers of anti-cellulite products, which are mainly acquired in the pharmacy, though sometimes without pharmaceutical advice. While considered more efficacious (either alone or in combination with topical), food supplements were less consumed than cosmetics, probably due to the increased risk perception associated with the first. In fact, anti-cellulite products, especially those marketed as food supplements, are not without adverse effects and contraindications. Pharmaceutical counseling on dispensing anti-cellulite products is thus critical and should be regarded as a differentiating factor of the place of acquisition and an added-value to the product.  References:  1. Luebberding, S., Krueger, N. & Sadick, N. Cellulite: an evidence-based review. Am. J. Clin Dermatol, 2015; 16: 243–56.  2. Turati, F. et al. Efficacy of cosmetic products in cellulite reduction: systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2014; 28(1):1-15. 3. Green, J.B., Cohen, J.L., Kaufman, J., Metelitsa, A.I., Kaminer, M.S. Therapeutic approaches to cellulite. Semin Cutan Med Surg. 2015:34(3):140-3.  Acknowledgements: Pharmacies (Caldense, Rosa, Santa Catarina, Tornada), where the application of the questionnaire was authorized, and their collaborators are gratefully acknowledged. 

A snapshot of anti-cellulite products' consumption and pharmaceutical intervention

https://comum.rcaap.pt/bitstream/10400.26/29095/1/Poster_AFernandes_2018_02.pdf

A snapshot of anti-cellulite products' consumption and pharmaceutical intervention

Abstract

Similar works

Full text

Available Versions

Repositório Comum

Repositório Comum